{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1166.103",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2021-10-12T01:02:02.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "OPA Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2022-12-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-10-12"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.103",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1166.103"
    }
  ],
  "version" : "20211012",
  "name" : "FemaleSterilizationHCPCSDevices",
  "title" : "Female Sterilization HCPCS Devices",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-10-12T01:02:02-04:00",
  "publisher" : "OPA Steward",
  "description" : "For Contraceptive eCQMs Approval for Trial Use application in Spring 2022; This set of values contains codes for female sterilization for contraception (e.g., bilateral tubal ligation, bilateral salpingectomy).",
  "jurisdiction" : [
    {
      "extension" : [
        {
          "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
          "valueString" : "UNKNOWN"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: Family planning - provision and use of most and moderately effective contraceptive methods),(Data Element Scope: Device codes indicating female sterilization, a most effective method of contraception.),(Inclusion Criteria: Device codes indicating female sterilization (e.g., bilateral tubal ligation), a most effective method of contraception.),(Exclusion Criteria: Any contraceptive method that is not female sterilization; Most effective (i.e., IUDs or IUSs, contraceptive implants) or moderately effective (i.e., injectables, oral pills, patch, or ring) methods of contraception; Less effective methods of contraception (i.e., diaphragm, male condom, female condom, withdrawal, sponge, fertility-awareness based methods, spermicide))",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "concept" : [
          {
            "code" : "A4264",
            "display" : "Permanent implantable contraceptive intratubal occlusion device(s) and delivery system"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:5aa3425d-a089-4549-8835-71866324d7e9",
    "timestamp" : "2023-06-29T17:23:21-04:00",
    "total" : 1,
    "offset" : 0,
    "parameter" : [
      {
        "name" : "count",
        "valueInteger" : 1000
      },
      {
        "name" : "offset",
        "valueInteger" : 0
      }
    ],
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2023",
        "code" : "A4264",
        "display" : "Permanent implantable contraceptive intratubal occlusion device(s) and delivery system"
      }
    ]
  }
}
